{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:45:48Z","timestamp":1785527148981,"version":"3.56.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004823","name":"Nagoya University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004823","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10549-026-07975-9","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:36:19Z","timestamp":1781674579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extracellular vesicles in nipple discharge for breast cancer screening"],"prefix":"10.1007","volume":"217","author":[{"given":"Yuri","family":"Ozaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Velaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Iwase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyone","family":"Kikumori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Nagahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Ebata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kajiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norikazu","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"7975_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"7975_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1001\/jama.2023.25881","volume":"331","author":"JL Caswell-Jin","year":"2024","unstructured":"Caswell-Jin JL et al (2024) Analysis of Breast Cancer Mortality in the US-1975 to 2019. JAMA 331:233\u2013241","journal-title":"JAMA"},{"key":"7975_CR3","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1001\/jama.2024.5534","volume":"331","author":"WK Nicholson","year":"2024","unstructured":"Nicholson WK et al (2024) Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 331:1918\u20131930","journal-title":"JAMA"},{"key":"7975_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10549-011-1787-5","volume":"132","author":"L Chen","year":"2012","unstructured":"Chen L et al (2012) Bloody nipple discharge is a predictor of breast cancer risk: a meta-analysis. Breast Cancer Res Treat 132:9\u201314","journal-title":"Breast Cancer Res Treat"},{"key":"7975_CR5","first-page":"471","volume":"178","author":"H G\u00fclay","year":"1994","unstructured":"G\u00fclay H, Bora S, K\u00ecl\u00ec\u00e7turgay S, Hamalo\u011flu E, G\u00f6ksel HA (1994) Management of nipple discharge. J Am Coll Surg 178:471\u2013474","journal-title":"J Am Coll Surg"},{"key":"7975_CR6","first-page":"20180016","volume":"1","author":"G Panzironi","year":"2019","unstructured":"Panzironi G, Pediconi F, Sardanelli F (2019) Nipple discharge: The state of the art. BJR Open 1:20180016","journal-title":"BJR Open"},{"key":"7975_CR7","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s10549-010-0815-1","volume":"123","author":"I Montroni","year":"2010","unstructured":"Montroni I et al (2010) Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excision. Breast Cancer Res Treat 123:895\u2013900","journal-title":"Breast Cancer Res Treat"},{"key":"7975_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2214\/AJR.16.16682","volume":"209","author":"N Berger","year":"2017","unstructured":"Berger N et al (2017) Diagnostic Performance of MRI Versus Galactography in Women With Pathologic Nipple Discharge: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol 209:465\u2013471","journal-title":"AJR Am J Roentgenol"},{"key":"7975_CR9","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.diii.2015.07.004","volume":"96","author":"N Lippa","year":"2015","unstructured":"Lippa N, Hurtevent-Labrot G, Ferron S, Boisserie-Lacroix M (2015) Nipple discharge: The role of imaging. Diagn Interv Imaging 96:1017\u20131032","journal-title":"Diagn Interv Imaging"},{"key":"7975_CR10","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00330-014-3521-2","volume":"25","author":"N Lubina","year":"2015","unstructured":"Lubina N et al (2015) 3.0 Tesla breast magnetic resonance imaging in patients with nipple discharge when mammography and ultrasound fail. Eur Radiol 25:1285\u20131293","journal-title":"Eur Radiol"},{"key":"7975_CR11","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3348\/kjr.2021.0850","volume":"23","author":"Y Choi","year":"2022","unstructured":"Choi Y et al (2022) The Value of Adding Ductography to Ultrasonography for the Evaluation of Pathologic Nipple Discharge in Women with Negative Mammography. Korean J Radiol 23:866\u2013877","journal-title":"Korean J Radiol"},{"key":"7975_CR12","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.6004\/jnccn.2018.0083","volume":"16","author":"TB Bevers","year":"2018","unstructured":"Bevers TB et al (2018) Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 16:1362\u20131389","journal-title":"J Natl Compr Canc Netw"},{"key":"7975_CR13","first-page":"103625","volume":"77","author":"N Jiwa","year":"2022","unstructured":"Jiwa N et al (2022) Nipple aspirate fluid and its use for the early detection of breast cancer. Ann Med Surg (Lond) 77:103625","journal-title":"Ann Med Surg (Lond)"},{"key":"7975_CR14","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1245\/s10434-021-11070-2","volume":"29","author":"N Jiwa","year":"2022","unstructured":"Jiwa N et al (2022) Diagnostic Accuracy of Nipple Discharge Fluid Cytology: A Meta-Analysis and Systematic Review of the Literature. Ann Surg Oncol 29:1774\u20131786","journal-title":"Ann Surg Oncol"},{"key":"7975_CR15","doi-asserted-by":"publisher","first-page":"9546","DOI":"10.3390\/ijms15069546","volume":"15","author":"G Wang","year":"2014","unstructured":"Wang G et al (2014) Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer. Int J Mol Sci 15:9546\u20139565","journal-title":"Int J Mol Sci"},{"key":"7975_CR16","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1245\/s10434-016-5163-x","volume":"23","author":"A Shidfar","year":"2016","unstructured":"Shidfar A et al (2016) Genetic Determinants of Nipple Aspiration Fluid Yield. Ann Surg Oncol 23:2487\u20132493","journal-title":"Ann Surg Oncol"},{"key":"7975_CR17","doi-asserted-by":"publisher","first-page":"24778","DOI":"10.18632\/oncotarget.8352","volume":"7","author":"JS de Groot","year":"2016","unstructured":"de Groot JS et al (2016) DNA promoter hypermethylation in nipple fluid: a potential tool for early breast cancer detection. Oncotarget 7:24778\u201324791","journal-title":"Oncotarget"},{"issue":"Suppl 3","key":"7975_CR18","doi-asserted-by":"publisher","first-page":"S536","DOI":"10.1245\/s10434-015-4586-0","volume":"22","author":"K Zhang","year":"2015","unstructured":"Zhang K et al (2015) Identification of microRNAs in Nipple Discharge as Potential Diagnostic Biomarkers for Breast Cancer. Ann Surg Oncol 22(Suppl 3):S536\u2013544","journal-title":"Ann Surg Oncol"},{"key":"7975_CR19","doi-asserted-by":"crossref","unstructured":"Wang S et al (2022) Identification of Three circulating MicroRNAs in plasma as clinical biomarkers for breast cancer detection. J Clin Med 12","DOI":"10.3390\/jcm12010322"},{"key":"7975_CR20","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.3892\/ol.2017.5801","volume":"13","author":"K Zhang","year":"2017","unstructured":"Zhang K, Wang YW, Ma R (2017) Bioinformatics analysis of dysregulated microRNAs in the nipple discharge of patients with breast cancer. Oncol Lett 13:3100\u20133108","journal-title":"Oncol Lett"},{"key":"7975_CR21","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s13402-021-00641-w","volume":"44","author":"SIS Patuleia","year":"2021","unstructured":"Patuleia SIS et al (2021) The changing microRNA landscape by color and cloudiness: a cautionary tale for nipple aspirate fluid biomarker analysis. Cell Oncol (Dordr) 44:1339\u20131349","journal-title":"Cell Oncol (Dordr)"},{"key":"7975_CR22","doi-asserted-by":"crossref","unstructured":"Shaheed SU et al (2017) Nipple aspirate fluid-A liquid biopsy for diagnosing breast health. Proteom Clin Appl 11","DOI":"10.1002\/prca.201700015"},{"key":"7975_CR23","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H et al (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654\u2013659","journal-title":"Nat Cell Biol"},{"key":"7975_CR24","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.cell.2023.03.010","volume":"186","author":"R Kalluri","year":"2023","unstructured":"Kalluri R, McAndrews KM (2023) The role of extracellular vesicles in cancer. Cell 186:1610\u20131626","journal-title":"Cell"},{"key":"7975_CR25","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA et al (2024) Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles 13:e12404","journal-title":"J Extracell Vesicles"},{"key":"7975_CR26","doi-asserted-by":"publisher","first-page":"7006","DOI":"10.1002\/cam4.2572","volume":"8","author":"M Li","year":"2019","unstructured":"Li M et al (2019) A five-miRNA panel in plasma was identified for breast cancer diagnosis. Cancer Med 8:7006\u20137017","journal-title":"Cancer Med"},{"key":"7975_CR27","doi-asserted-by":"publisher","first-page":"9650","DOI":"10.18632\/oncotarget.2520","volume":"5","author":"C Eichelser","year":"2014","unstructured":"Eichelser C et al (2014) Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients. Oncotarget 5:9650\u20139663","journal-title":"Oncotarget"},{"key":"7975_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4103\/cjop.CJOP-D-22-00138","volume":"66","author":"YW Wang","year":"2023","unstructured":"Wang YW et al (2023) Breast cancer nipple discharge exosomal microRNAs are stable under degradative conditions. Chin J Physiol 66:181\u2013187","journal-title":"Chin J Physiol"},{"key":"7975_CR29","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1097\/CM9.0000000000001043","volume":"133","author":"YW Wang","year":"2020","unstructured":"Wang YW et al (2020) Exosomes exist in nipple discharge of breast cancer. Chin Med J (Engl) 133:2378\u20132380","journal-title":"Chin Med J (Engl)"},{"key":"7975_CR30","doi-asserted-by":"publisher","first-page":"6915","DOI":"10.1038\/s41467-023-42593-9","volume":"14","author":"A Yokoi","year":"2023","unstructured":"Yokoi A et al (2023) Spatial exosome analysis using cellulose nanofiber sheets reveals the location heterogeneity of extracellular vesicles. Nat Commun 14:6915","journal-title":"Nat Commun"},{"key":"7975_CR31","doi-asserted-by":"crossref","unstructured":"Nu\u00f1ez DL et al (2020) Papillary lesions of the breast: a review. Breast Cancer Manag 9","DOI":"10.2217\/bmt-2020-0028"},{"key":"7975_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrc3932","volume":"15","author":"S Lin","year":"2015","unstructured":"Lin S, Gregory RI (2015) MicroRNA biogenesis pathways in cancer. Nat Rev Cancer 15:321\u2013333","journal-title":"Nat Rev Cancer"},{"key":"7975_CR33","doi-asserted-by":"crossref","unstructured":"Kuriyama N et al (2021) Challenges for the development of extracellular vesicle-based nucleic acid medicines. Cancers (Basel) 13","DOI":"10.3390\/cancers13236137"},{"key":"7975_CR34","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1038\/s41418-020-0555-7","volume":"27","author":"JT Lu","year":"2020","unstructured":"Lu JT et al (2020) FOXF2 deficiency accelerates the visceral metastasis of basal-like breast cancer by unrestrictedly increasing TGF-\u03b2 and miR-182-5p. Cell Death Differ 27:2973\u20132987","journal-title":"Cell Death Differ"},{"key":"7975_CR35","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.ymthe.2019.05.011","volume":"27","author":"Y Sang","year":"2019","unstructured":"Sang Y et al (2019) circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p\/FOXO3a Axis in Breast Cancer. Mol Ther 27:1638\u20131652","journal-title":"Mol Ther"},{"key":"7975_CR36","doi-asserted-by":"publisher","first-page":"995","DOI":"10.21037\/atm-20-5192","volume":"8","author":"X Wu","year":"2020","unstructured":"Wu X, Chen H, Wu M, Peng S, Zhang L (2020) Downregulation of miR-182-5p inhibits the proliferation and invasion of triple-negative breast cancer cells through regulating TLR4\/NF-\u03baB pathway activity by targeting FBXW7. Ann Transl Med 8:995","journal-title":"Ann Transl Med"},{"key":"7975_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s10020-021-00338-8","volume":"27","author":"C Lu","year":"2021","unstructured":"Lu C et al (2021) Breast cancer cell-derived extracellular vesicles transfer miR-182-5p and promote breast carcinogenesis via the CMTM7\/EGFR\/AKT axis. Mol Med 27:78","journal-title":"Mol Med"},{"key":"7975_CR38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41598-019-56571-z","volume":"10","author":"XH Gao","year":"2020","unstructured":"Gao XH et al (2020) MicroRNA-96-5p represses breast cancer proliferation and invasion through Wnt\/\u03b2-catenin signaling via targeting CTNND1. Sci Rep 10:44","journal-title":"Sci Rep"},{"key":"7975_CR39","doi-asserted-by":"publisher","first-page":"e3188","DOI":"10.1002\/jgm.3188","volume":"22","author":"WY Qin","year":"2020","unstructured":"Qin WY, Feng SC, Sun YQ, Jiang GQ (2020) MiR-96-5p promotes breast cancer migration by activating MEK\/ERK signaling. J Gene Med 22:e3188","journal-title":"J Gene Med"},{"key":"7975_CR40","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/1759-7714.13348","volume":"11","author":"Z Yin","year":"2020","unstructured":"Yin Z et al (2020) MiRNA-96-5p impacts the progression of breast cancer through targeting FOXO3. Thorac Cancer 11:956\u2013963","journal-title":"Thorac Cancer"},{"key":"7975_CR41","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1373\/clinchem.2015.238691","volume":"61","author":"N Matamala","year":"2015","unstructured":"Matamala N et al (2015) Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection. Clin Chem 61:1098\u20131106","journal-title":"Clin Chem"},{"key":"7975_CR42","doi-asserted-by":"publisher","first-page":"707049","DOI":"10.3389\/fcell.2021.707049","volume":"9","author":"G Liang","year":"2021","unstructured":"Liang G et al (2021) MiR-92b-3p Inhibits Proliferation of HER2-Positive Breast Cancer Cell by Targeting circCDYL. Front Cell Dev Biol 9:707049","journal-title":"Front Cell Dev Biol"},{"key":"7975_CR43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12957-021-02347-7","volume":"19","author":"Y Du","year":"2021","unstructured":"Du Y et al (2021) Expression levels and clinical values of miR-92b-3p in breast cancer. World J Surg Oncol 19:239","journal-title":"World J Surg Oncol"},{"key":"7975_CR44","doi-asserted-by":"crossref","unstructured":"Lisencu LA et al (2022) The Role of miR-375-3p, miR-210-3p and Let-7e-5p in the pathological response of breast cancer patients to neoadjuvant therapy. Med (Kaunas) 58","DOI":"10.3390\/medicina58101494"},{"key":"7975_CR45","doi-asserted-by":"crossref","unstructured":"Santana MFM et al (2023) Increased expression of miR-223-3p and miR-375-3p and anti-inflammatory activity in HDL of newly diagnosed women in advanced stages of breast cancer. Int J Mol Sci 24","DOI":"10.3390\/ijms241612762"},{"key":"7975_CR46","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s13258-021-01200-1","volume":"44","author":"S Yu","year":"2022","unstructured":"Yu S, Zhou Y, Niu L, Qiao Y, Yan Y (2022) Mesenchymal stem cell-derived exosome mir-342-3p inhibits metastasis and chemo-resistance of breast cancer through regulating ID4. Genes Genomics 44:539\u2013550","journal-title":"Genes Genomics"},{"key":"7975_CR47","doi-asserted-by":"publisher","first-page":"101333","DOI":"10.1016\/j.tranon.2021.101333","volume":"18","author":"Q Liu","year":"2022","unstructured":"Liu Q, Zhang J, Liu Y, Peng H, Wu Y (2022) Extracellular vesicles extracted from bone marrow mesenchymal stem cells carrying MicroRNA-342-3p inhibit the INHBA\/IL13R\u03b12 axis to suppress the growth and metastasis of breast cancer. Transl Oncol 18:101333","journal-title":"Transl Oncol"},{"key":"7975_CR48","doi-asserted-by":"publisher","first-page":"12252","DOI":"10.1038\/s41598-018-29708-9","volume":"8","author":"SL Romero-Cordoba","year":"2018","unstructured":"Romero-Cordoba SL et al (2018) Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer. Sci Rep 8:12252","journal-title":"Sci Rep"},{"key":"7975_CR49","doi-asserted-by":"publisher","first-page":"108385","DOI":"10.1016\/j.abb.2020.108385","volume":"687","author":"C Liu","year":"2020","unstructured":"Liu C, Xing H, Luo X, Wang Y (2020) MicroRNA-342 targets Cofilin 1 to suppress the growth, migration and invasion of human breast cancer cells. Arch Biochem Biophys 687:108385","journal-title":"Arch Biochem Biophys"},{"key":"7975_CR50","doi-asserted-by":"crossref","unstructured":"Curtaz CJ et al (2022) Analysis of microRNAs in exosomes of breast cancer patients in search of molecular prognostic factors in brain metastases. Int J Mol Sci 23","DOI":"10.3390\/ijms23073683"},{"key":"7975_CR51","first-page":"1267","volume":"44","author":"AD Martinez-Gutierrez","year":"2019","unstructured":"Martinez-Gutierrez AD et al (2019) miRNA profile obtained by next\u2013generation sequencing in metastatic breast cancer patients is able to predict the response to systemic treatments. Int J Mol Med 44:1267\u20131280","journal-title":"Int J Mol Med"},{"key":"7975_CR52","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1016\/S0140-6736(24)00425-2","volume":"403","author":"S Delaloge","year":"2024","unstructured":"Delaloge S, Khan SA, Wesseling J, Whelan T (2024) Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment. Lancet 403:2734\u20132746","journal-title":"Lancet"},{"key":"7975_CR53","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1056\/NEJMoa1600249","volume":"375","author":"HG Welch","year":"2016","unstructured":"Welch HG, Prorok PC, O\u2019Malley AJ, Kramer BS (2016) Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness. N Engl J Med 375:1438\u20131447","journal-title":"N Engl J Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07975-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-07975-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07975-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:09:18Z","timestamp":1785521358000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-026-07975-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["7975"],"URL":"https:\/\/doi.org\/10.1007\/s10549-026-07975-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"22 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki and approved by the Ethics Committee of Nagoya University School of Medicine (Approval no. 2023-0066).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants prior to enrollment.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"53"}}